LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin

• Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data

CAMBRIDGE, Massachusetts, Oct. 16, 2017 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc., a gene-therapy company with a mission to develop cures for early-onset life-threatening diseases, announced today that